Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro

Chinese Medical Journal

Volumn 122, Issue 11, 2009, Pages 1300-1304

  Wang, Xiao Yi ^a   Tan, Jin Xiang ^a   Vasse, Marc ^b   Delpech, Bertrand ^b,c   Ren, Guo Sheng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ DE ROUEN   (France)

^c CENTRE HENRI BECQUEREL   (France)

Author keywords

Angiogenesis; Breast neoplasms; Hyaluronidase; Invasion; Peptide hydrolases; Receptors, estrogen

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; GELATINASE B; HEPARIN; HYALURONIDASE; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CATHEPSIN D; CELL LINE, TUMOR; HUMANS; HYALURONOGLUCOSAMINIDASE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68249141222     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.11.012     Document Type: Article

References (30)

1. Clark GM, Sledge GW, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 1987; 5: 55-61.
2. Thompson DA, Weigel RJ. Characterization of a gene that is inversely correlated with oestrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem 1998; 252: 169-177.
3. Platet N, Prevostel C, Derocq D, Joubert D, Rochefort H, Garcia M. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in oestrogen receptor-positive and -negative cells. Int J Cancer 1998; 75: 750-756.
4. Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000; 21: 505-515.
5. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to cancer progression. Mol Med Today 2000; 6: 149-156.
6. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, et al. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-betal in human breast cancer cells. Oncogene 2001; 20: 8066-8074.
7. Rochefort H, Liaudet E, Garcia M. Alterations and role of human cathepsin D in cancer metastasis. Enzyme Protein 1996; 49: 106-116.
8. Csoka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q21. Genomics 1999; 60: 356-361.
9. Cameron E. Hyaluronidase and cancer. Oxford: Pergamon Press; 1966: 181-192.
10. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996; 56: 651-657.
11. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1996; 93: 7832-7837.
12. Bertrand P, Girard N, Duval C, D'anjou J, Chauzy C, Menard JF, et al. Increased hyaluronidase levels in breast tumor metastases. Int J Cancer 1997; 73: 327-331.
13. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228: 1324-1326.
14. Trochon V, Mabilat-Pragnon C, Bertrand P, Legrand Y, Soria J, Soria C, et al. Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro. FEBS Lett 1997; 418: 6-10.
15. Chao KL, Muthukumar L, Herzberq O. Structure of human hyaluronidase-1, ahyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry 2007; 46: 6911-6920.
16. Bharadwai AG, Rector K, Simpson MA. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis. J Biol Chem 2007; 282: 20561-20572.
17. Hall RE, Tilley WD, Mcphaul MJ, Sutherland RL. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int J Cancer 1992; 52: 778-784.
18. Schneider SM, Offterdinger M, Huber H, Grunt TW. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47 D human breast cancer cells. Cancer Res 2000; 60: 5479-5487.
19. Chernicky CL, Yi L, Tan H, Gan SU, Ilan J. Treatment of human breast cancer cells with antisense RNA to the I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Cancer Gene Ther 2000; 7: 384-395.
20. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978; 38: 3352-3364.
21. Delpech B, Bertrand P, Maingonnat C, Girard N, Chauzy C. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal Biochem 1995; 229: 35-41.
22. Asteriou T, Deschrevel B, Delpech B, Bertrand P, Bultelle F, Merai C, et al. An improved assay for the N-acetyl-D-glucosamine reducing ends of polysaccharides in the presence of proteins. Anal Biochem 2001; 293: 53-59.
23. van de Vijver M, Bilous M, Hanna W, Hofmann M, Kristel P, Penault-Llorca F, et al. Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study. Breast Cancer Res 2007; 9: R68.
24. Pluciennik E, Kusinska R, Potemski P, Kubiak R, Kordek R, Bednarek AK. WWOX - the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol 2006; 32: 153-157.
25. Tagliabue E, Menard S, Robertson JF, Harris L. c-erbB-2 expression in primary breast cancer. Int J Biol Markers 1999; 14: 16-26.
26. Gasparini G. Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 2001; 37: 97-114.
27. Heer K, Kumar H, Read JR, Fox JN, Monson JR, Kerin MJ. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and oestrogen receptor status. Clin Cancer Res 2001; 7: 3491-3494.
28. Lokeshwar VB, Cerwinka WH, Lokeshwar BL. HYAL1 hyaluronidase: a moleculardeterminant of bladder tumor growth and invasion. Cancer Res 2005; 65: 2243-2250.
29. Chao KL, Muthukumar L, Herzberq O. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. Biochemistry 2007; 46: 6911-6920.
30. Borsig L. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Semin Thromb Hemost 2007; 33: 540-546.